Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. QLGN

Market Closed
20 Nov, 20:00
NASDAQ (CM) NASDAQ (CM)
$
3. 87
+0.01
+0.26%
$
2.01M Market Cap
- P/E Ratio
0% Div Yield
40,500 Volume
-2.7 Eps
$ 3.86
Previous Close
Day Range
3.67 4.05
Year Range
3.34 39.15
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
12 Nov 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
14 Aug 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
13 Aug 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
12 Jul 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
28 May 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
27 May 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
22 May 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
29 Mar 2024
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
14 Nov 2023
-
Cons. EPS
-
EPS
Qualigen Therapeutics, Inc. logo
QLGN Qualigen Therapeutics, Inc.
13 Nov 2023
-
Cons. EPS
-
EPS